We are live on ! Find out more
VAR

Varian Medical Systems, Inc.
VAR

Delisted

VAR was delisted on the 14th of April, 2021.

597 hedge funds and large institutions have $11.7B invested in Varian Medical Systems, Inc. in 2019 Q4 according to their latest regulatory filings, with 92 funds opening new positions, 172 increasing their positions, 210 reducing their positions, and 41 closing their positions.

New
Increased
Maintained
Reduced
Closed

400% more funds holding in top 10

Funds holding in top 10: 15 (+4)

134% more call options, than puts

Call options by funds: $34.7M | Put options by funds: $14.8M

124% more first-time investments, than exits

New positions opened: 92 | Existing positions closed: 41

19% more capital invested

Capital invested by funds: $9.81B → $11.7B (+$1.91B)

6% more funds holding

Funds holding: 562597 (+35)

18% less repeat investments, than reductions

Existing positions increased: 172 | Existing positions reduced: 210

Holders
597
Holders Change
+35
Holders Change %
+6.23%
% of All Funds
11.76%
Holding in Top 10
5
Holding in Top 10 Change
+4
Holding in Top 10 Change %
+400%
% of All Funds
0.1%
New
92
Increased
172
Reduced
210
Closed
41
Calls
$34.7M
Puts
$14.8M
Net Calls
+$19.9M
Net Calls Change
+$4.03M
Name Holding Trade Value Shares
Change
Change in
Stake
PWLP
251
Prio Wealth Limited Partnership
Massachusetts
$1.67M -$25.5K -200 -2%
KeyBank National Association
252
KeyBank National Association
Ohio
$1.64M +$185K +1,447 +14%
JIM
253
Jensen Investment Management
Oregon
$1.63M +$45.9K +360 +3%
CC
254
Cognios Capital
Kansas
$1.56M -$792K -6,209 -36%
Jacobs Levy Equity Management
255
Jacobs Levy Equity Management
New Jersey
$1.56M -$1.91M -14,994 -58%
CWM
256
CIBC World Markets
New York
$1.53M -$2.81M -21,996 -67%
OC
257
Oppenheimer & Co
New York
$1.52M +$25.5K +200 +2%
DAM
258
Diamant Asset Management
Connecticut
$1.51M -$38.3K -300 -3%
DCM
259
Dupont Capital Management
Delaware
$1.48M
QI
260
QS Investors
New York
$1.46M -$178K -1,397 -12%
Pacer Advisors
261
Pacer Advisors
Pennsylvania
$1.44M -$225K -1,761 -15%
RMCM
262
Reynders McVeigh Capital Management
Massachusetts
$1.44M -$60.6K -475 -4%
VFA
263
Values First Advisors
Tennessee
$1.44M +$1.3M +10,154 New
WA
264
Wealth Architects
California
$1.42M
KFC
265
Klingenstein Fields & Co
New York
$1.41M -$8.29K -65 -0.7%
V
266
Veritable
Delaware
$1.39M -$9.44K -74 -0.7%
LOAMS
267
Lombard Odier Asset Management (Switzerland)
Switzerland
$1.38M -$909K -7,127 -42%
BAM
268
Blueshift Asset Management
New Jersey
$1.36M +$1.22M +9,599 New
HIMCH
269
Hartford Investment Management Co (HIMCO)
Connecticut
$1.36M -$31.3K -245 -2%
Creative Planning
270
Creative Planning
Kansas
$1.34M -$14.2K -111 -1%
AIM
271
Achmea Investment Management
Netherlands
$1.31M -$719K -5,639 -38%
SAM
272
Securian Asset Management
Minnesota
$1.31M -$40.6K -318 -3%
II
273
IFM Investors
Australia
$1.28M -$57.7K -452 -5%
B
274
BP
United Kingdom
$1.28M
CIBC Asset Management
275
CIBC Asset Management
Ontario, Canada
$1.26M +$27.8K +218 +3%

VAR Hedge Fund Activity: Q4 2019 in Review

597 of the 5,076 institutional investors tracked by Wall St. Rank reported a position in Varian Medical Systems, Inc. (VAR) for Q4 2019, worth a combined $11.7B — up 19% from $9.81B a quarter earlier.

Buyers outnumbered sellers: 92 funds opened new VAR positions and 41 closed out — a net gain of 51 holders — while 172 added to existing stakes and 210 trimmed.

The largest buyer was Marshall Wace North America, adding an estimated $91.4M. The largest seller was Loomis, Sayles & Company, cutting an estimated $164M.

  • 597 institutional investors held Varian Medical Systems, Inc. (VAR) as of Q4 2019, up from 562 in Q3 2019.
  • Funds reported $11.7B of Varian Medical Systems, Inc. stock for Q4 2019, up 19% quarter-over-quarter.
  • 92 funds opened new Varian Medical Systems, Inc. positions in Q4 2019 and 41 closed out, a net change of +51 holders.
  • The largest Varian Medical Systems, Inc. buyer in Q4 2019 was Marshall Wace North America, an estimated $91.4M added.
  • The largest Varian Medical Systems, Inc. seller in Q4 2019 was Loomis, Sayles & Company, an estimated $164M sold.

Based on aggregated 13F filings for Q4 2019.